HeartBeam says device showed 81.8% vs 71.4% specificity against standard ECG in heart attack pilot study; plans US pivotal study in Q1 2027

HeartBeam says its device showed 81.8% vs 71.4% specificity against standard ECG in a heart attack pilot study, and plans a U.S. pivotal study in Q1 2027.

Detected & updated continuously · Source: Nebula